N(2)-substituted D,L-cycloserine derivatives: synthesis and evaluation as alanine racemase inhibitors

J Antibiot (Tokyo). 2003 Feb;56(2):160-8. doi: 10.7164/antibiotics.56.160.

Abstract

A select series of N(2)-substituted D,L-cycloserine derivatives were prepared a ndevaluated for inhibitory activity against purified alanine racemases (alr gene product) from Escherichia coli, Staphylococcus aureus, and Mycobacterium tuberculosis, as well as in a growth inhibition assay. N(2)-Modification led to loss of enzymatic inhibitory activity in most cases consistent with a recent proposal for cycloserine function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alanine Racemase / antagonists & inhibitors*
  • Alanine Racemase / metabolism
  • Antibiotics, Antitubercular / chemical synthesis*
  • Antibiotics, Antitubercular / chemistry
  • Antibiotics, Antitubercular / pharmacology
  • Chromatography, Thin Layer
  • Cycloserine / analogs & derivatives*
  • Cycloserine / pharmacology
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology
  • Mass Spectrometry
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / enzymology
  • Nuclear Magnetic Resonance, Biomolecular
  • Spectroscopy, Fourier Transform Infrared
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / enzymology
  • Structure-Activity Relationship

Substances

  • Antibiotics, Antitubercular
  • Enzyme Inhibitors
  • Cycloserine
  • Alanine Racemase